|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Investments, at fair value (amortized cost of $373,465 and $495,797, respectively) | ||||||||||||||
| Non-controlled/non-affiliate company investments | ||||||||||||||
| Non-controlled affiliate company investments | ||||||||||||||
| Controlled affiliate company investments | ||||||||||||||
| Total investments, at fair value (amortized cost of $373,465 and $495,797, respectively) | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Restricted cash | ||||||||||||||
| Unrealized gain on foreign currency forward contracts | ||||||||||||||
| Interest and dividend receivable | ||||||||||||||
| Distribution receivable from affiliate | ||||||||||||||
| Other assets | ||||||||||||||
| Total assets | ||||||||||||||
| Liabilities | ||||||||||||||
| Debt | ||||||||||||||
| Revolving credit facility | ||||||||||||||
| 2026 Notes | ||||||||||||||
| Total debt | ||||||||||||||
| Less: Unamortized debt issuance costs | ||||||||||||||
| Debt, less unamortized debt issuance costs | ||||||||||||||
| 2026 Notes | ||||||||||||||
| Total debt, less unamortized debt issuance costs | ||||||||||||||
| Interest payable | ||||||||||||||
| Base management fees payable | ||||||||||||||
| Incentive fees payable | ||||||||||||||
| Payable for unsettled trades | ||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||
| Directors' fees payable | ||||||||||||||
| Total liabilities | ||||||||||||||
| Net assets | ||||||||||||||
| Net Assets | ||||||||||||||
| Common stock, $0.001 par value, 100,000 shares authorized, 21,666 and 21,666 shares issued and outstanding, respectively | ||||||||||||||
| Capital in excess of par value | ||||||||||||||
| Accumulated undistributed (overdistributed) earnings | ||||||||||||||
| Total net assets | ||||||||||||||
| Total liabilities and total net assets | ||||||||||||||
| Net asset value per share (in dollars per share) | ||||||||||||||
Loading...